Position in NVAX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,837
-$87,366 QoQ
Shares Held
2,106
-84.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#187
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 17%
None 41%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. NVAX ranks #108 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,837 | 2,106 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $107,203 | 13,170 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $86,774 | 12,913 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $115,587 | 13,332 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $91,248 | 14,484 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $77,246 | 12,051 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $94,920 | 11,806 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $155,336 | 12,299 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $4,279 | 338 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $8,690 | 1,818 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $5,736 | 1,195 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $42,867 | 5,921 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $63,645 | 8,566 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $34,234 | 4,940 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $22,461 | 2,185 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $48,302 | 2,654 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $116,744 | 2,270 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $153,411 | 2,083 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $210,169 | 1,469 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $419,802 | 2,025 | Shares | Other | 2021-11-10 | |
| 2021-06-30 | $449,672 | 2,118 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $878,990 | 4,848 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $747,785 | 6,706 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $614,777 | 5,674 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $304,810 | 3,657 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $5,432 | 400 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||